ARIPIPRAZOLE LONG-ACTING INJECTION (Abilify Maintena®)
Clinical Indication
Maintenance treatment of schizophrenia in patients currently stabilised on oral aripiprazole
Date of classification
September 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .